Laidlaw Group’s Merck MRK Stock Holding History

Laidlaw Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$211K	Sell	3,886 -1,100	-22%	-$61.7K	0.1%	72
2015 Q1	$273K	Sell	4,986 -996	-17%	-$56.4K	0.13%	65
2014 Q4	$324K	Buy	5,982 +629	+12%	+$35K	0.15%	64
2014 Q3	$303K	Sell	5,353 -105	-2%	-$5.9K	0.15%	65
2014 Q2	$301K	Sell	5,458 -861	-14%	-$47K	0.15%	66
2014 Q1	$342K	Sell	6,319 -1,730	-21%	-$89.6K	0.18%	63
2013 Q4	$384K	Buy	8,049 +79	+1%	+$3.61K	0.21%	65
2013 Q3	$362K	Hold	7,970	–	–	0.21%	64
2013 Q2	$353K	Buy	+7,970	New	+$356K	0.2%	64

Other funds holding MRK

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Laidlaw Group's MRK Position: Q2 2015 in Review

Laidlaw Group reduced its Merck (MRK) stake by 22% in Q2 2015, selling an estimated $61.7K and leaving 3,886 shares worth $211K. The position accounts for 0.1% of the portfolio, ranked #72.

Laidlaw Group first reported a position in MRK in Q2 2013 and has held it in 9 quarters since. The position peaked at $384K in Q4 2013. 1,725 funds tracked by Wall St. Rank hold MRK as of Q2 2015.

Laidlaw Group held 3,886 shares of Merck worth $211K as of Q2 2015.
Laidlaw Group sold 1,100 Merck shares in Q2 2015, an estimated $61.7K.
Merck made up 0.1% of Laidlaw Group's portfolio in Q2 2015, its #72 holding.
Laidlaw Group first reported a position in Merck in Q2 2013 and has held it in 9 quarters since.
Laidlaw Group's Merck position peaked at $384K in Q4 2013.
1,725 funds tracked by Wall St. Rank held Merck as of Q2 2015.

Based on Laidlaw Group's 13F filing for Q2 2015, filed 31 Jul 2015.